Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup study - Pediatric Oncology Group 9048 and Children's Cancer Group 8891

Journal of Clinical Oncology

Volumn 22, Issue 17, 2004, Pages 3563-3569

  Rogers, Paul C ^a   Olson, Thomas A ^a   Cullen, John W ^a   Billmire, Deborah F ^a   Marina, Neyssa ^a   Rescorla, Frederick ^a   Davis, Mary M ^a   London, Wendy B ^a   Latter, Stephen J ^a   Giller, Roger H ^a   Cushing, Barbara ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT; BEP PROTOCOL;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD TOXICITY; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DOSE RESPONSE; GERM CELL TUMOR; HUMAN; INFANT; LOW DRUG DOSE; LUNG TOXICITY; MAJOR CLINICAL STUDY; NEPHROTOXICITY; OTOTOXICITY; OVARY TUMOR; PEDIATRICS; PRIORITY JOURNAL; SIDE EFFECT; TESTIS CANCER; ADULT; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; MALE; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; TESTIS TUMOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; GERMINOMA; HUMANS; MALE; NEUTROPENIA; OVARIAN NEOPLASMS; TESTICULAR NEOPLASMS;

EID: 4444279138     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.01.006     Document Type: Article

References (47)

1. Mulligan RM: Pathogenesis of teratoid tumors of the ovary and testis. Pathol Annu 10:271-298, 1975
2. Kurman RJ, Norris HJ: Endodermal sinus tumor of the ovary: A clinical and pathologic analysis of 71 cases. Cancer 38:2404-2419, 1976
3. Chretien PB, Milam JD, Foote FW, et al: Embryonal adenocarcinomas (a type of malignant teratoma) of the sacrococcygeal region. Clinical and pathologic aspects of 21 cases. Cancer 26:522-535, 1970
4. Slayton RE, Hreshchyshyn MM, Silverberg SC, et al: Treatment of malignant ovarian germ cell tumors: Response to vincristine, dactinomycin, and cyclophosphamide (preliminary report). Cancer 42:390-398, 1978
5. Cangir A, Smith J, van Eys J: Improved prognosis in children with ovarian cancers following modified VAC (vincristine sulfate, dactinomycin, and cyclophosphamide) chemotherapy. Cancer 42:1234-1238, 1978
6. Carlson RW, Sikic BI, Turbow MM, et al: Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary. J Clin Oncol 1:645-651, 1983
7. Einhorn LH, Donohue J: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular ćancer. Ann Intern Med 87:293-298, 1977
8. Einhorn LH: Chemotherapy of disseminated germ cell tumors. Cancer 60:570-573, 1987
9. Israel A. Bosl GJ, Golbey RB, et al: The results of chemotherapy for extragonadal germ-cell tumors in the cisplatin era: The Memorial Sloan-Kettering Cancer Center experience (1975 to 1982). J Clin Oncol 3:1073-1078, 1985
10. Logothetis CJ, Samuels ML, Selig DE, et al: Chemotherapy of extragonadal germ cell tumors. J Clin Oncol 3:316-325, 1985
11. Pizzocaro G, Salvioni R, Pasi M, et al: Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer. Cancer 56:249-255, 1985
12. Williams SD, Blessing JA, Moore DH, et al: Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med 111:22-27, 1989
13. Chiuten D, Vogl S, Kaplan B, et al: Is there cumulative or delayed toxicity from cis-platinum? Cancer 52:211-214, 1983
14. Comis RL: Bleomycin pulmonary toxicity: Current status and future directions. Semin Oncol 19:64-70, 1992
15. Exelby PR: Testicular cancer in children. Cancer 45:1803-1809, 1980
16. Mann JR, Pearson D, Barrett A, et al: Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer 63:1657-1667, 1989
17. Green DM: The diagnosis and treatment of yolk sac tumors in infants and children. Cancer Treat Rev 10:265-288, 1983
18. Marina N, Fontanesi J, Kun L, et al: Treatment of childhood germ cell tumors. Review of the St. Jude experience from 1979 to 1988. Cancer 70:2568-2575, 1992
19. Pinkerton CR, Pritchard J, Spitz L: High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy. J Clin Oncol 4:194-199, 1986
20. Perlman EJ, Hu J, Ho D, et al: Genetic analysis of childhood endodermal sinus tumors by comparative genomic hybridization. J Pediatr Hematol Oncol 22:100-105, 2000
21. Schneider DT, Schuster AE, Fritsch MK, et al: Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Klin Padiatr 213:204-211, 2001
22. Marina NM, Gushing B, Giller R, et al: Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol 17:2137-2143, 1999
23. Schlatter M, Rescorla F, Giller R, et al: Excellent outcome in patients with stage I germ cell tumors of the testes: A study of the Children's Cancer Group/Pediatric Oncology Group. J Pediatr Surg 38:319-324, 2003
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
25. Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J R Stat Soc A 135:185-198, 1972
26. Ablin AR, Krailo MD, Ramsay NK, et al: Results of treatment of malignant germ cell tumors in 93 children: A report from the Children's Cancer Study Group. J Clin Oncol 9:1782-1792, 1991
27. Flamant F, Schwartz L, Delons E, et al: Nonseminomatous malignant germ cell tumors in children. Multidrug therapy in stages III and IV. Cancer 54:1687-1691, 1984
28. Hopkins TB, Jaffe N, Colodny A, et al: The management of testicular tumors in children. J Urol 120:96-102, 1978
29. Haas RJ, Schmidt P, Gobel U, et al: Treatment of malignant testicular tumors in childhood: Results of the German National Study 1982-1992. Med Pediatr Oncol 23:400-405, 1994
30. Haas RJ, Schmidt P, Gobel U, et al: Testicular germ cell tumors. Results of the GPO MAHO studies -82, -88, -92. Klin Padiatr 207:145-150, 1995
31. Haas RJ, Schmidt P, Gobel U, et al: Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997. Klin Padiatr 211:300-304, 1999
32. Baranzelli MC, Patte C: The French experience in paediatric malignant germ cell tumours, in Jones WG, Appleyard L. Hamden P, Joffe JK (eds): Germ Cell Tumours IV. London, United Kingdom, John Libbey and Co Ltd, 1998, pp 219-226
33. Mann JR, Raafat F, Robinson K, et al: The United Kingdom Children's Cancer Study Group's second germ cell tumor study: Carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 18:3809-3818, 2000
34. Brodeur GM, Howarth CB, Pratt CB, et al: Malignant germ cell tumors in 57 children and adolescents. Cancer 48:1890-1898, 1981
35. Micha JP, Kucera PR, Berman ML, et al: Malignant ovarian germ cell tumors: A review of thirty-six cases. Am J Obstet Gynecol 152:842-846, 1985
36. Schwanz PE: Combination chemotherapy in the management of ovarian germ cell malignancies. Obstet Gynecol 64:564-572, 1984
37. Baranzelli MC, Flamant F, De Lumley L, et al: Treatment of non-metastatic, non-seminomatous malignant germ-cell tumours in childhood: Experience of the "Societe Francaise d'Oncologie Pediatrique" MGCT 1985-1989 study. Med Pediatr Oncol 21:395-401, 1993
38. Dark GG, Bower M, Newlands ES, et al: Surveillance policy for stage I ovarian germ cell tumors. J Clin Oncol 15:620-624, 1997
39. Baranzelli MC, Bouffet E, Quintana E, et al: Non-seminomatous ovarian germ cell tumours in children. Eur J Cancer 36:376-383, 2000
40. Gobel U, Calaminus G, Engert J, et al: Teratomas in infancy and childhood. Med Pediatr Oncol 31:8-15, 1998
41. Olson TA, Cullen JW, Lauer SJ, et al: Low dose bleomycin every three weeks with cisplatin and etoposide results in excellent event free survival and survival in children and adolescents with gonadal malignant germ cell tumors (MGCT). A POG/CCG study. Proc Am Soc Clin Oncol 22:798, 2003 (abstr)
42. Nichols CR, Hoffman R, Einhorn LH, et al: Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med 102:603-609, 1985
43. Nichols CR, Roth BJ, Heerema N, et al: Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 322:1425-1429, 1990
44. Hartmann JT, Nichols CR, Droz JP, et al: Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst 92:54-61, 2000
45. Ozols RF, Deisseroth AB, Javadpour N, et al: Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen. Cancer 51:1803-1807, 1983
46. Ozols RF, Ihde DC, Linehan WM, et al: A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors. J Clin Oncol 6:1031-1040, 1988
47. Dalgleish AG, Woods RL, Levi JA: Bleomycin pulmonary toxicity: Its relationship to renal dysfunction. Med Pediatr Oncol 12:313-317, 1984